USPTO serial 79329886
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles G. Zug
Charles G. Zug Nelson Mullins Riley & Scarborough LLP301 South College StreetSuite 2300, IP DepartmentCharlotte, NC 28202| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs for medical purposes for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable computer programs for health purposes for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable computer application software for use in the provision of and access to medical treatment; downloadable computer application software for the provision of medical and health information; downloadable computer application software for recording, collection, organisation, management and transmission of medical and health information; downloadable software for use with medical devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; downloadable software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical treatment; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of health and for providing information to patients and doctors in relation to epilepsy, other neurological conditions and cardiac conditions, and the diagnosis, monitoring, management and treatment thereof; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of epilepsy and for providing information to patients and doctors in relation to epilepsy, other neurological conditions and cardiac conditions, and the diagnosis, monitoring, management and treatment thereof; downloadable computer database programs relating to medical and health information for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; downloadable databases, namely, downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical and health information and for providing information to patients and doctors in relation to epilepsy, other neurological conditions and cardiac conditions, and the diagnosis, monitoring, management and treatment thereof | ACTIVE | — |
| 010 | Medical apparatus for diagnostic purposes, namely, medical apparatus for diagnosing neurological and cardiac conditions; apparatus for medical diagnosis, namely, medical apparatus for diagnosing neurological and cardiac conditions; apparatus for medical diagnostic purposes, namely, medical apparatus for diagnosing neurological and cardiac conditions; Apparatus for medical purposes, namely medical apparatus for diagnosing, monitoring, managing and treating neurological and cardiac conditions; Apparatus for sale in kit form for medical diagnostic purposes, namely wearable and portable EEG/ECG monitors, video camera, water soluble adhesives, electrode refills, repair gel, and shower cap; Electro medical apparatus, namely wearable and portable EEG and ECG monitors; Electronic apparatus for medical use with computers, namely wearable and portable EEG and ECG monitors; Electronic monitoring apparatus for medical use, namely wearable and portable EEG and ECG monitors; Medical apparatus for the diagnosis of neurological diseases; electronic medical apparatus for diagnosis of neurological conditions; electronic medical apparatus for neurological monitoring | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring software for medical purposes for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; software as a service (SAAS) services featuring software for health purposes for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; software as a service (SAAS) services featuring software for use in the provision of and access to medical treatment; software as a service (SAAS) services featuring software for the provision of medical and health information; software as a service (SAAS) services featuring software for recording, collection, organisation, management and transmission of medical and health information; software as a service (SAAS) services featuring software for use with medical devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; software as a service (SAAS) services featuring software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; software as a service (SAAS) services featuring software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological and cardiac conditions; software as a service (SAAS) services featuring software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; software as a service (SAAS) services featuring software for use in the management of epilepsy for monitoring and diagnosing neurological diseases | ACTIVE | — |
| 044 | Advisory services relating to medical problems; advisory services relating to medical services; health care consultancy services, namely, consulting services in the field of medical care; medical advisory services; medical analysis services relating to the treatment of patients; medical assistance; medical care services; medical counselling; medical testing and medical analysis services, all for diagnostic purposes; providing medical information; medical services; medical services in the field of neurology; medical advisory services relating to the treatment of epilepsy; medical advisory services relating to the management of epilepsy | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 11, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 12, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 18, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 16, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 4, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 4, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 4, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 4, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 4, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 20, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 17, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 14, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 13, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 30, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |